Skip to content

One in six South Africans drug resistant before starting HIV treatment

Sizulu Moyo presenting at CROI 2019. Photo by Roger Pebody.

People stay on PrEP for 14 months on average in the US, study finds

Slide from Ya-Lin Huang's presentation at CROI 2019.

Are CD4 counts still useful in the 'treat all' era?

Are CD4 counts still useful in the 'treat all' era?

Multiple benefits to scaling up universal test and treat in Africa

Avatar_023/Shutterstock.com

Long-acting injectable treatment maintains viral suppression

Susan Swindells and Chloe Orkin presenting at CROI 2019. Photo by Liz Highleyman.

‘Molecular scissors’ successfully remove HIV genes from all tissues in infected monkeys

Tricia Burdo at CROI 2019. Photo by Liz Highleyman.

Integrase inhibitor treatment leads to greater weight gain

Slide from Jane O'Halloran's presentation at CROI 2019.

How many people who have used PrEP get HIV the same year? New York study finds out

How many people who have used PrEP get HIV the same year? New York study finds out

Chronic obstructive pulmonary disease (COPD) increases the risk of heart attack in people with HIV

Kristina Crothers presenting at CROI 2019. Photo by Liz Highleyman.